Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Industry Insights
Global Pharma Morale On A New High
The CPhI 2022 poll measured the potential for growth in each of the 12 major pharmaceutical markets of the world, and results were the highest ever this year.
Gene Therapy Transactions Give Wall Street Cautious Optimism
These deals are a promising development for a field of drug development that generated a great lot of interest a few years ago but has since seen limitations.
As established firms look to new biotechs for innovation, Pharma M&A has grown considerably with a focus on immune system ailments, cancer, and rare diseases.
Since the India-UK deal will entail regulatory cooperation with UK Regulatory Agency for Medicines and Healthcare Products, the drug companies should benefit.
UK R&D Worldwide Spending Share £62bn Short, Data Shows
To boost economic development and re-establish worldwide leadership of UK, the Institute for Public Policy Research recommends increasing R&D expenditure.
Blood Cells Generated In Lab Transfused Into First Patients
The administration of lab-grown blood cells to a second patient may pave the pathway for future treatments for blood disorders including sickle cell disease.